Practice question

Answer the question and get instant feedback.

MediumCardiologyPrimary prevention-statin intoleranceus-abfmus-abimus-usmle-step-2

A 55-year-old woman with no ASCVD has LDL-C 110 mg/dL and 10-year ASCVD risk 9%. She declines statins. What nonstatin therapy has modest LDL-C lowering and outcome benefit when statins are not tolerated?

Educational content. Not a substitute for clinical judgement or local policy.